Oblenio Bio

Oblenio Bio aims to transform the treatment of severe autoimmune diseases, putting the promise of immune reset in reach for millions of patients. The company is focused on achieving the significant potential of T-cell engagers as a novel therapeutic approach that addresses underlying disease pathophysiology and achieves immune reset.